Assembly Biosciences (ASMB) Depreciation & Amortization (CF) (2010 - 2026)
Assembly Biosciences (ASMB) posted quarterly Depreciation & Amortization (CF) of $26000.0 for Q1 2026, down 21.21% year-over-year from $33000.0 in Q1 2025, and down 18.75% quarter-over-quarter from $32000.0 in Q4 2025.
Assembly Biosciences (ASMB) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Assembly Biosciences' Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $26000.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 21.21% year-over-year to $26000.0; the TTM figure through Mar 2026 stood at $122000.0 (down 6.15% YoY), while the FY2025 annual figure was $129000.0, changed 0.0% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $26000.0, down from $32000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $134000.0 in Q3 2022, with the low at $26000.0 in Q1 2026.
- The 5-year median for Depreciation & Amortization (CF) is $33000.0 (2024), against an average of $72470.6.
- The sharpest annual moves came in 2022 and 2024: Depreciation & Amortization (CF) grew 12.61% in 2022, then plunged 74.6% in 2024.
- Assembly Biosciences' Depreciation & Amortization (CF) stood at $124000.0 in 2022, then sank by 32.26% to $84000.0 in 2023, then plunged by 61.9% to $32000.0 in 2024, then changed by 0.0% to $32000.0 in 2025, then fell by 18.75% to $26000.0 in 2026.
- Business Quant data shows ASMB's Depreciation & Amortization (CF) at $26000.0 in Q1 2026, $32000.0 in Q4 2025, and $32000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.10 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 40.52 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.18 Mn |
| 10 | Assembly Biosciences | 670.88 Mn | 350.52 Mn | - | 20,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20,000.00 |
| Jun 30, 2026 | 20,000.00 |
| Mar 31, 2026 | 26,000.00 |
| Mar 31, 2026 | 26,000.00 |
| Dec 31, 2025 | 32,000.00 |
| Dec 31, 2025 | 32,000.00 |
| Sep 30, 2025 | 32,000.00 |
| Sep 30, 2025 | 32,000.00 |
| Jun 30, 2025 | 32,000.00 |
| Jun 30, 2025 | 32,000.00 |
| Mar 31, 2025 | 33,000.00 |
| Mar 31, 2025 | 33,000.00 |
| Dec 31, 2024 | 32,000.00 |
| Dec 31, 2024 | 32,000.00 |
| Sep 30, 2024 | 33,000.00 |
| Sep 30, 2024 | 33,000.00 |
| Jun 30, 2024 | 32,000.00 |
| Jun 30, 2024 | 32,000.00 |
| Mar 31, 2024 | 32,000.00 |
| Mar 31, 2024 | 32,000.00 |